Nuvve Holding (NASDAQ:NVVE) reported quarterly losses of $(2.70) per share. This is a 718.18 percent decrease over losses of $(0.33) per share from the same period last year.
Sigilon Therapeutics Q3 EPS $(0.27) Up From $(0.63) YoY, Sales $4.25M Up From $1.95M YoY
Sigilon Therapeutics (NASDAQ:SGTX) reported quarterly losses of $(0.27) per share. This is a 57.14 percent increase over losses of $(0.63) per share from the same period last year. The company reported $4.25 million in
